Immune Checkpoint Inhibitor-related Pancreatitis: A Case Series, Review of the Literature and an Expert Opinion

被引:10
作者
Kramer, Sjoerd [1 ]
van Hee, Koen [2 ]
Blokzijl, Hans [1 ]
van der Heide, Frans [1 ]
Visschedijk, Marijn C. C. [1 ]
机构
[1] Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Hanzeplein 1, NL-9713 GZ Groningen, Netherlands
[2] Jeroen Bosch Hosp, Dept Gastroenterol & Hepatol, sHertogenbosch, Netherlands
关键词
immune checkpoint inhibitors; autoimmune pancreatitis; chronic pancreatitis; steroid dependent; steroid failure;
D O I
10.1097/CJI.0000000000000472
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of various malignancies, but are associated with serious adverse events like pancreatitis. Current guidelines are limited to the first step in treating acute ICI-related pancreatitis with steroids but lack treatment advices for steroid dependent pancreatitis. We describe a case series of 3 patients who developed ICI-related pancreatitis with chronic features such as exocrine insufficiency and pancreatic atrophy at imaging. Our first case developed after treatment with pembrolizumab. The pancreatitis responded well after discontinuation of immunotherapy but imaging showed pancreatic atrophy and exocrine pancreatic insufficiency persisted. Cases 2 and 3 developed after treatment with nivolumab. In both, pancreatitis responded well to steroids. However during steroid tapering, pancreatitis recurred and the latter developed exocrine pancreatic insufficiency and pancreatic atrophy at imaging. Our cases demonstrate resemblances with autoimmune pancreatitis based on clinical and imaging findings. In line, both diseases are T-cell mediated and for autoimmune pancreatitis azathioprine is considered as maintenance therapy. Guidelines of other T-cell mediated diseases like ICI-related hepatitis suggest tacrolimus. After adding tacrolimus in case 2 and azathioprine in case 3, steroids could be completely tapered and no new episodes of pancreatitis have occurred. These findings support the idea that the treatment modalities for other T-cell mediated diseases are worthwhile options for steroid dependent ICI-related pancreatitis.
引用
收藏
页码:271 / 275
页数:5
相关论文
共 21 条
[1]   Immunoglobulin G4 associated autoimmune cholangitis and pancreatitis following the administration of nivolumab: A case report [J].
Agrawal, Rohit ;
Guzman, Grace ;
Karimi, Saman ;
Giulianotti, Pier Cristoforo ;
Lora, Alfredo Jose Mena ;
Jain, Shikha ;
Khan, Meshaal ;
Boulay, Brian R. ;
Chen, Yolande .
WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (20) :7124-7129
[2]   Management of Autoimmune Pancreatitis [J].
Akshintala, Venkata S. ;
Singh, Vikesh K. .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (10) :1937-1939
[3]   The effects of glucocorticoids and immunosuppressants on cancer outcomes in checkpoint inhibitor therapy [J].
Bruera, Sebastian ;
Suarez-Almazor, Maria E. E. .
FRONTIERS IN ONCOLOGY, 2022, 12
[4]   Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity [J].
Bylsma, Sophia ;
Yun, Karen ;
Patel, Sandip ;
Dennis, Michael J. .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (09) :1153-1168
[5]  
Champion Benjamin, 2023, Pathology, V55, P133, DOI 10.1016/j.pathol.2022.04.010
[6]   Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: implications for the management of irAEs [J].
Draghi, Arianna ;
Borch, Troels Holz ;
Radic, Haja Dominike ;
Chamberlain, Christopher Aled ;
Gokuldass, Aishwarya ;
Svane, Inge Marie ;
Donia, Marco .
INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (05) :1408-1413
[7]   Incidence of pancreatitis with the use of immune checkpoint inhibitors (ICI) in advanced cancers: A systematic review and meta-analysis [J].
George, John ;
Bajaj, Divyansh ;
Sankaramangalam, Kesavan ;
Yoo, Jin Woo ;
Joshi, Nikhil S. ;
Gettinger, Scott ;
Price, Christina ;
Farrell, James J. .
PANCREATOLOGY, 2019, 19 (04) :587-594
[8]   Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy [J].
Haanen, John ;
Ernstoff, Marc ;
Wang, Yinghong ;
Menzies, Alexander ;
Puzanov, Igor ;
Grivas, Petros ;
Larkin, James ;
Peters, Solange ;
Thompson, John ;
Obeid, Michel .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (01)
[9]   Workup and Management of Immune-Mediated Hepatobiliary Pancreatic Toxicities That Develop During Immune Checkpoint Inhibitor Treatment [J].
Hsu, Christine ;
Marshall, John L. ;
He, Aiwu Rum .
ONCOLOGIST, 2020, 25 (02) :105-111
[10]   Immunotherapy-Associated Pancreatic Adverse Events: Current Understanding of Their Mechanism, Diagnosis, and Management [J].
Liu, Ya ;
Zhang, Hao ;
Zhou, Li ;
Li, Weichun ;
Yang, Le ;
Li, Wen ;
Li, Kezhou ;
Liu, Xubao .
FRONTIERS IN ONCOLOGY, 2021, 11